Kristen Carpenter
Obstetrics & Gynecology · Morgantown, WVNPI 1376932673
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,311 of the $4,931 with a category attached, or 87.4%. 22 manufacturers reported payments, led by Astellas Pharma US Inc at 28.2% of the total. 2025 is the largest year on record at $1,331, 3.0 times the $437 reported in 2021.
Across 249 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$1K
- Sumitomo Pharma America, Inc.$749
- Amgen$477
- AbbVie$474
- Exeltis, USA Inc.$306
- Mayne Pharma Commercial LLC$262
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,31187%
- Education$62013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 47 | $1,391 |
| Sumitomo Pharma America, Inc. | 46 | $749 |
| Amgen | 22 | $477 |
| AbbVie | 31 | $474 |
| Exeltis, USA Inc. | 19 | $306 |
| Mayne Pharma Commercial LLC | 16 | $262 |
| Organon | 15 | $247 |
| Urovant Sciences Inc | 9 | $173 |
| Mylan Pharmaceuticals Inc. | 9 | $146 |
| Bayer | 4 | $124 |
| Therapeuticsmd, Inc. | 7 | $110 |
| Pfizer | 5 | $95 |
| Millicent US Inc | 5 | $93 |
| Hologic Sales And Service, LLC | 3 | $66 |
| Novo Nordisk | 3 | $50 |
| Axonics, Inc. | 1 | $41 |
| Virtus Pharmaceuticals LLC | 2 | $39 |
| Convatec Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $15 |
| Provepharm Inc. | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,931 in reported general payments places this provider in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.
See all obstetrics & gynecology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 98 | $98,419 |
| GemtesaVibegron | 58 | $46,641 |
| Estradiol | 345 | $25,004 |
| ProliaDenosumab | 13 | $22,277 |
| PremarinEstrogens, Conjugated | 26 | $10,495 |
| YuvafemEstradiol | 31 | $6,314 |
| Methenamine Hippurate | 80 | $5,059 |
| Oxybutynin Chloride ErOxybutynin Chloride | 154 | $3,900 |
| Clobetasol Propionate | 103 | $2,208 |
| Solifenacin Succinate | 40 | $1,799 |
| Estradiol (Once Weekly)Estradiol | 14 | $1,707 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 17 | $1,634 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,448 |
| Trospium Chloride | 12 | $1,345 |
| Nystatin | 69 | $870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,391 | $98,41998 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $749 | $46,64158 claims |
| AmgenProlia | $477 | $22,27713 claims |
| PfizerPremarin | $95 | $10,49526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.
Other obstetrics & gynecology in Morgantown
- Sarah DotsonMorgantown$24K
- Cynthia WalshMorgantown$5K
- Craig HerringMorgantown$3K
- Candina McCulloughMorgantown$2K
- Jessica HottMartinsburg$194K
- Lori TuckerPrinceton$46K
- Stephen BushCharleston$33K
- Amanda PauleyHuntington$26K
- Juddson LindleyBeckley$19K
- David RaineyBeckley$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.